Undisclosed Clinical Lead Candidates

About IDBiologics

IDBiologics is a private, clinical-stage biotech company based in Memphis, Tennessee, specializing in antibody therapeutics for infectious diseases. The company's core asset is an innovative, fully human monoclonal antibody discovery and optimization platform originating from Vanderbilt University, enabling rapid development of candidates with demonstrated proof-of-concept in animal models. With six clinical lead candidate molecules targeting diverse pathogens and a recent contract from the Department of Defense, IDBiologics is positioned to address significant unmet medical needs in pandemic preparedness and endemic infections. The company operates as a pre-revenue entity advancing a pipeline from pre-clinical and clinical development.

Therapeutic Areas